| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w5306 |
| 来源ID | Working Paper 5306 |
| \"Generic Entry and the Pricing of Pharmaceuticals\" | |
| Richard G. Frank; David S. Salkever | |
| 发表日期 | 1995-10-01 |
| 出版年 | 1995 |
| 语种 | 英语 |
| 摘要 | During the 1980s the share of prescriptions sold by retail pharmacies that was accounted for by generic products roughly doubled. The price response to generic entry of brand-name products has been a source of controversy. In this paper we estimate models of price responses to generic entry in the market for brand-name and generic drugs. We study a sample of 32 drugs that lost patent protection during the early to mid-1980s. Our results provide strong evidence that brand-name prices increase after entry and are accompanied by large price decreases in the price of generic drugs. |
| URL | https://www.nber.org/papers/w5306 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/562758 |
| 推荐引用方式 GB/T 7714 | Richard G. Frank,David S. Salkever. \"Generic Entry and the Pricing of Pharmaceuticals\". 1995. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w5306.pdf（219KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
